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ABSTRACT  
Mammographic % density, the proportion of fibroglandular tissue in the breast, is a strong risk factor 
for breast cancer, but its determinants in young women are unknown. We examined associations 
between magnetic resonance imaging (MRI) breast-tissue composition at age 21 years and 
prospectively-collected measures of body size and composition from birth to early adulthood, and 
markers of puberty (all standardized), in a sample of 500 nulliparous women from a pre-birth cohort 
of children born in Avon, England, in 1991-1992 and followed up to 2011-2014. Linear models were 
fitted to estimate relative change in MRI % water, which is equivalent to mammographic % density, 
associated with one standard deviation increase in the exposure of interest. In mutually-adjusted 
analyses, MRI % water was positively associated with birth weight (relative change=1.03 (95% 
confidence interval: 1.00, 1.06)) and pubertal height growth (1.07 (1.02, 1.13)), but inversely 
associated with pubertal weight growth (0.86 (0.84, 0.89)) and changes in dual-energy x-ray 
absorptiometry % body fat mass (e.g. 0.96 (0.93, 0.99)), for change between ages 11-13.5 years). 
Ages at thelarche and menarche were positively associated with MRI % water, but these associations 
did not persist upon adjustment for height and weight growth. These findings support the hypothesis 
that growth trajectories influence breast-tissue composition in young women, whereas puberty plays 
no independent role.          
  
KEYWORDS  
Breast cancer, breast density, breast size, height, weight, childhood, puberty, ALSPAC 
 
LIST OF ABBREVIATIONS: 
ALSPAC: Avon Longitudinal Study of Parents and Children 
BMI: body mass index 
CI: confidence interval 
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DXA: dual energy x-ray absorptiometry 
IQR: inter-quartile range 
MRI: magnetic resonance imaging 
RC: relative change in MRI breast measure associated one standard deviation increase in the exposure 
of interest  
SD: standard deviation 
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There is established evidence of a positive association of childhood height (1) with breast 
cancer risk later in life, whilst late age at menarche (2) and higher adolescent body mass index (BMI) 
have been found to be protective (3).  Childhood and adolescent growth patterns are hypothesised to 
be associated with levels of sex and growth hormones, with these potentially affecting breast 
development and, hence, subsequent breast cancer risk (4).  Age- and BMI-adjusted mammographic 
% density, which represents the proportion of fibro-glandular tissue in the breast accounting for a 
woman’s age and BMI, is one of the strongest predictors of breast cancer risk (5).  Thus, a possible 
mechanism through which early-life body size and maturation may influence breast cancer risk is 
through breast-tissue composition. 
Several studies have suggested possible associations between mammographic % density in 
late adulthood and early-life growth, body fatness and pubertal development (6-8). However, few 
have investigated the influence of body growth trajectories from birth to young adulthood on breast-
tissue composition based on prospectively-collected life-course data. Furthermore, existing studies 
have mostly recruited women of screening ages, who had already experienced reproductive-related 
events and who therefore have an altered breast-tissue composition.  As yet, there has been no 
investigation of the influence of childhood and adolescence growth trajectories on breast-tissue 
composition in young nulliparous women.  
In this study, we investigate the relationship between prospectively-collected growth 
measures from birth to early adulthood, including height and weight trajectories and markers of 
pubertal development and body composition, with absolute (i.e. breast size and its components) and 
relative measures of breast-tissue composition in young nulliparous women within a British pre-birth 
cohort.   
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METHODS 
Study population 
The study is nested within the Avon Longitudinal Study of Parents and Children (ALSPAC) 
(9, 10), a prospective pre-birth cohort of 14,775 children born in Avon, England, between April 1st 
1991 and December 31st 1992 (representing 72% of the eligible population (9)).  Nulliparous women 
born from singleton pregnancies, who participated regularly in follow-up surveys were invited to 
attend a magnetic resonance imaging (MRI) examination of their breasts at the University of Bristol 
Clinical Research and Imaging Centre between June 2011-November 2014.  Women who had ever 
been diagnosed with cancer or a hormone-related disease, or had contra-indications for MRI (e.g. 
pregnancy, metal implants), were excluded.  Of the 2,530 potentially eligible women invited, 500 
(19.8%) attended.  The low response rate reflects the inconvenience of participating in the study (i.e. 
time and travel to the MRI examination centre) and relocation away from the study area (i.e. to attend 
university).  However, socio-demographic and anthropometric measures were similar in eligible 
women who did and did not participate in the study. For example, mean birthweight and height at 
ages 7 and 16 years were 3390.9g (standard deviation, SD=21.6g), 125.6cm (SD=0.32cm) and 
165.5cm (SD=0.32cm), respectively, in participants, and 3397.4g (SD=11.4g), 125.5cm (SD=0.13cm) 
and 165.0cm (SD=0.20cm), respectively, amongst non-participating eligible women.     
The study received approval from the ALSPAC Law and Ethics Committee, the National 
Research Ethics Service Committee South West - Frenchay, and the London School of Hygiene and 
Tropical Medicine ethics committee. Participants provided written informed consent. 
Growth and development measures 
Participant’s birth weight and length were collected from obstetric records.  Height and 
weight measures from birth to 5 years were available from health visitor records, which form part of 
standard childcare in Britain. On average, up to 4 measurements were taken at 2, 10, 21, and 48 
months of age.  Between ages 4 months and 5 years, direct height and weight measurements were 
taken for a random 10% of the cohort every ≈6 months.  All cohort members were invited to annual 
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clinics from age 7 to 13 years, and at ages 15 and 17 years, during which standing height (without 
shoes) and weight were measured using the Harpenden stadiometer (Holtain Ltd., Crosswell, UK) and 
Tanita-305 Body Fat Analyses (Tanita Corp., Tokyo, Japan), respectively. Total body and trunk fat, 
bone and lean masses were measured using a Lunar Prodigy dual-energy x-ray absorptiometry (DXA) 
scanner (GE Medical Systems Lunar, Madison, WI) at ages 9, 11, 13.5 and 15.5 years.   
Age of menarche was asked during clinic visits at ages 12-13 years. Annual puberty 
questionnaires were also sent to participants between ages 8 and 17 years, during which breast and 
pubic hair development was recorded by either the mother or child prior to age 14 years, and 
participants only thereafter. We assumed participants were at Tanner stage 1 if the breast assessment 
at age 8 years was missing.  
During the MRI breast examination (at age ~21 years), participants completed a short 
questionnaire on menstrual-related variables, and anthropometric measurements were taken using a 
standard protocol. 
The study website contains details of all available data through a fully searchable data 
dictionary (11). 
Breast-tissue composition assessment 
The breast-tissue composition assessment methodology is described in (12).  Briefly, each 
participant underwent a non-contrast MRI examination using a 3T Siemens Skyra system (Siemens 
Healthcare Ltd., Camberley, UK) and a set of T1-weighted VIBE 3-D images (≈176 images/woman), 
with a voxel size of 0.76x0.76x0.90mm3, and T2-weighted trans-axial images (≈40 images/woman), 
with in-plane resolution 0.85x0.85 mm2 and slice thickness of 4mm, of both breasts were obtained.  
Fully-automated algorithms were developed to estimate breast volume using both T1-weighted and 
T2-weighted images, and perform fat/water segmentation on T2-weighted images. Left-right average 
estimates of volumes (in cm3) of breast, water and fat (the latter two correspond to mammographic 
dense and non-dense tissues, respectively), as well as % water, were generated. Percent water is 
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highly positively correlated with mammographic % density on the same women (13-15). Valid breast 
parameters were obtained for 491 of the 500 participants who underwent the MRI examination. 
Statistical analysis  
To examine associations between participants’ MRI breast values and the available height and 
weight measurements, two sets of growth summaries were generated (standardised using respective 
sample mean and SD).  The first were observed pre-pubertal and pubertal/post-pubertal (hereafter 
referred as pubertal) height and weight growth increments, where age at onset of breast development, 
i.e. age at thelarche (described below), was used as a marker of each girl’s onset of puberty.  Thus, 
pre-pubertal growth was calculated by subtracting height or weight at age 7 years from height or 
weight at age of thelarche, whilst pubertal growth was calculated by subtracting height or weight at 
age of thelarche from height or weight at age 21 years (both standardised after subtraction).  
The second set of growth summaries was derived using linear spline multilevel models. 
Standardised measures (z-scores) of rate of height and weight growth during five periods (birth to 3 
months, 3 to 12 months, 1 to 3 years, and 3 to 7 years) had been derived previously and are fully 
described elsewhere (16). For this study, additional standardised measures of growth velocities from 
age 7 to 21 years were calculated using the same approach (16), i.e. piecewise linear mixed effect 
models (with three knots set at ages 10,12 and 15 years), to estimate height and weight velocities 
during four distinct periods: ages 7 to 10, 10 to 12, 12 to 15, and 15 to 21 years (Web Tables 1-2; Web 
Figures 1-2).   
DXA total body mass was estimated by summing fat, bone and lean masses, and % body bone 
and fat masses derived and standardised.  Changes in DXA % body bone and fat masses between ages 
9 and 11, 11 and 13.5, and 13.5 and 15.5 years were calculated and standardised.   
Age at thelarche was estimated using non-linear mixed models for the probability of 
transitioning from Tanner stage 1 to 2. Similarly, age of completion of breast development was 
estimated modelling the transition from Tanner stages 1/3 to 4/5.  Interpolation between predicted 
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probabilities gave the predicted age at transition used to calculate the first set of growth summaries 
described above.  
Linear models were fitted to study the relationship of MRI breast measures (i.e. breast, fat and 
water volumes; % water) with height/weight growth measures, puberty markers and changes in DXA 
body composition variables. Initial models consider the influence of each of these sets of dimensions, 
separately, while adjusting for age and menstrual phase at MRI examination. In the DXA models, age 
at DXA examination was also included. To achieve near-normal distributions of the residuals, breast 
tissue measures were log-transformed, but exponentiated estimated regression coefficients are 
presented; these represent the expected relative change (RC) in MRI breast measures associated with 
a unit increase in the exposure of interest. Growth measures, puberty markers and DXA variables 
were also modelled jointly as indicated in the tables and figures.  
Sensitivity analyses were conducted using multiple imputation by chain equations (17) to deal 
with missing exposure and confounder data under the missing at random assumption (18) to obtain 
results based on all participants with valid MRI breast measures (n=491).  The missing at random 
assumption was explored by comparing the distribution of observed variables among those 
with/without complete records.  Twenty imputed datasets were generated and overall estimates 
obtained using Rubin’s rules (19).  
Data analysis was conducted in STATA, version 14 (StataCorp LP, College Station, TX). All 
tests of significance are two-sided.  
 
RESULTS 
Study subjects 
Table 1 presents the distributions of puberty, DXA and MRI breast measures of participants.  
Figure 1 shows the median height, weight and % DXA body fat and bone masses by age, alongside 
the median age of selected puberty markers.  At age of thelarche (median=10.2 years; Table 1), 
median height and weight were 144cm (inter-quartile range (IQR)=7.5cm) and 37kg (IQR=10.3kg), 
OR
IG
IN
AL
 U
NE
DI
TE
D 
MA
NU
SC
RI
PT
 
Downloaded from https://academic.oup.com/aje/advance-article-abstract/doi/10.1093/aje/kwx358/4622593
by London School of Hygiene & Tropical Medicine user
on 08 February 2018
   
10 
 
respectively.  By age 21 years, participants had on average, grown 19.6cm (IQR=10.4cm) and gained 
24.6kg (IQR=13.7kg) in weight.  Over time, there was a high level of correlation across growth and 
DXA measures (Web Table 3); for example, 75.9%, 64.0% and 84.2% of participants remained in the 
same fifth for height between the ages of 7 and 8, 11 and 12, and 15 and 17 years. Weight at any 
given age was positively correlated with all available age-specific DXA % body fat mass estimates 
(Pearson regression coefficient, r=0.60-0.80; P<0.001 for all). Correlations between height 
measurements and DXA % body bone mass estimates were much weaker (r<0.20 for all).  
Participants who had an earlier thelarche were, on average, more likely to be younger at menarche and 
at the end of breast development, but breast development took longer, compared to those whose 
thelarche was at an older age (Web Figure 3). 
Growth trajectories and MRI breast-tissue composition  
In mutually-adjusted analyses of the first set of growth summaries (Figure 2), both pre-
pubertal and pubertal height growth increments were positively associated with % water but inversely 
associated with breast volume (Figure 2). One SD increase in pre-pubertal height growth (=8.3cm) 
was associated with an 18% (RC=1.18; 95% CI: 1.12, 1.24) higher % water and a 19% (0.81; 0.73, 
0.91) lower breast volume, with these changes being driven mainly by lower fat volume (Web Table 
4).  Similar associations were seen with pubertal height growth. In contrast, one SD increase in pre-
pubertal (=6.00kg) and pubertal weight growths (=11.44kg) were associated, respectively, with a 14% 
(RC=0.86; 95% CI: 0.83, 0.89) and a 16% (0.84; 0.82, 0.86) lower % water but a 23% (1.23; 1.14, 
1.34) and 79% (1.79; 1.68, 1.89) higher breast volume (Figure 2).  Weight, but not length, at birth was 
found to be independently (and positively) associated with % water (Figure 2). Examination of height 
and weight growth velocity estimates from birth to age 21 years, as derived by the linear spline 
multilevel models (Figure 3), showed similar patterns while highlighting the lack of association of 
height and weight velocity measures prior to age 7 years with total breast volume and % water. 
Markers of puberty were also associated with MRI breast measures. In mutually-adjusted 
analyses (Figure 2), age at thelarche and menarche were positively associated with % water, and age 
of thelarche and breast completion were inversely associated with breast volume. Age at breast 
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development completion did not affect breast-tissue composition, whilst age at menarche had no 
influence on breast volume. 
In mutually-adjusted analyses of the DXA variables, DXA % body fat mass at age 9, and 
increments from age 9 to 15.5 years, were all associated with a markedly higher breast volume, but 
lower % water, reflecting larger proportional increases in fat volume than water volume (Web Table 
4).  For example, one SD (=3.81%) increase in DXA % body fat mass between ages 9 and 11 years 
was associated with an 8% (RC=0.92; 95% CI: 0.90, 0.95) lower % water but a 22% (1.22; 1.13, 1.32) 
higher breast volume.  In contrast, there was some borderline evidence that DXA % body bone mass 
at age 9, and increments from age 9 to 15.5 years, were associated with higher % water but lower 
breast volume.  For example, one SD (=0.22%) increase in DXA % body bone mass between ages 9 
and 11 years was associated with a 2% (1.02; 0.99, 1.06) higher % water, but an 8% (0.92; 0.86, 1.00) 
lower breast volume (Figure 2). 
When the growth measures were modelled jointly with the puberty variables (Table 2-model 
1) the % water associations with birthweight, and pre-pubertal and pubertal height and weight growths 
persisted, with their magnitude being little affected, while its associations with all puberty markers 
were no longer present.  In contrast, when the growth measures were modelled jointly with the DXA 
variables (Table 2-model 2), % water was found to be independently associated with pubertal height 
and weight growths, but not with their pre-pubertal counterparts. Further inclusion of the puberty 
variables into the latter model (Table 2-model 3) affected little the magnitude of these associations.  
Thus, one SD increase in birth weight (=470g) and in pubertal height growth (=7.42cm) were 
associated, respectively, with a 3% (RC=1.03; 95% CI: 1.00, 1.06) and a 7% (1.07; 1.02, 1.13) higher 
% water, with no changes in breast volume, while one SD (=11.44kg) increase in pubertal weight 
growth was associated with a 14% lower (0.86; 0.84, 0.89) % water and a 70% higher (1.70; 1.58, 
1.82) breast volume. DXA % body fat mass at age 9 years, and changes from age 9 to 11 and from 11 
to 13.5 years, were also found to be independently associated with lower % water, but only DXA 
body fat mass at age 9 years was independently (and positively) associated with breast volume. DXA 
% body bone mass at age 9 years was positively related to % water, but did not influence breast 
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volume, whilst increments between ages 13.5 and 15.5 years were inversely associated with breast 
volume, but did not affect % water.   
Both height-adjusted weight and DXA % body fat mass capture body adiposity but the 
inverse association of % water with pubertal weight growth was associated with higher volumes of 
both fat and, to a lesser extent, water (fibro-glandular tissue) whereas the inverse associations of % 
water with DXA % body fat mass resulted entirely from higher fat volume, with no association with 
water volume (Web Table 5).   
Sensitivity analyses 
Some of the growth velocities included in our models were strongly correlated (particularly, 
height and weight pre-pubertal growth; Web Table 6) but examination of variance inflation factors for 
all variables included in models 1-3 found no evidence of multicollinearity, i.e. variance inflation 
factor <10 for all except pre-pubertal height velocity in model 3 for breast volume and % water 
(variance inflation factor=11.2). However, removal of pre-pubertal height velocity from these models 
changed minimally (at most ~15%) the standard errors of the other variables.  
Models that further adjusted for height and BMI at the MRI examination suffered from 
multicollinearity (e.g. Model 3, % water, BMI at 21 years:  variation inflation factor=34.5); hence, the 
results are not reported. Results were comparable when using multiple imputation under the missing 
at random assumption to deal with missing confounder and exposure data (Web Tables 7-8).  
 
DISCUSSION  
Findings from this unique study indicate that height and weight trajectories from birth to age 
21 years are associated with breast-tissue composition in young adulthood. Puberty does not affect 
breast-tissue composition independently of height and weight growth.   
Strengths and limitations 
Strengths of this study include the pre-birth cohort design with multiple indicators of growth, 
collected prospectively from birth to age 21 years. Breast-tissue measures were obtained from 
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ionising radiation-free MRI examinations, making this the first study to examine the influence of 
childhood and adolescent growth patterns on breast-tissue composition in young adulthood, prior to 
changes induced by pregnancies and breastfeeding. Fully-automated and, hence, observer-
independent volumetric breast-tissue composition measurements were taken using a previously-
developed and evaluated approach (12, 20).The response rate was low (≈20%), although comparable 
to a similar MRI breast study (15), but there was no evidence that participants were a biased sample.  
Data were missing for some variables but analyses of complete records and imputed datasets 
produced similar findings (albeit under the missing at random assumption). A weakness was the lack 
of information on age at peak height velocity or, its proxy, the age when adult height was attained. 
Consistency with other studies 
The finding of an independent association of birthweight with breast-tissue composition is in 
line with our previous investigation into the relationship between birth size and MRI breast measures 
in this cohort, as well as our recent systematic review  (20).  The observed strong independent inverse 
associations between % water and adiposity, as ascertained by weight and DXA % body fat mass, are 
also consistent with those from previous studies (6-8, 21-25). There is increasing evidence that 
childhood and adolescent weight is inversely associated with breast cancer risk in pre- (26) and post-
menopausal women (7, 26), with one study indicating that the association may be partly mediated by 
breast density (7).  
In our study, both pre-pubertal and pubertal height growth were positively associated with % 
water in mutually-adjusted analyses; however, the association with pre-pubertal height growth did not 
persist upon further adjustment for the DXA body fat mass measurements. As no DXA measurements 
were taken after age 15.5 years it is conceivable that the pubertal height growth association might be 
due to residual confounding. Two previous longitudinal cohorts did not reveal positive associations 
between adolescent height growth and breast density (6, 7).  Evidence from cross-sectional studies is 
mixed (15, 23, 24, 27).  Between-study heterogeneity may be due to variability in breast density 
assessment, with those using categorical or binary measures finding no associations with adolescent 
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height growth (6, 7, 27) whilst those based on quantitative methods detecting positive associations 
(15, 23, 24).    
Total body adiposity, as captured by height-adjusted weight and DXA % body fat mass, was 
inversely associated with % water but positively associated with breast volume. Interestingly, height-
adjusted weight was positively associated with both fat and water volumes whilst DXA % body fat 
mass was positively associated with fat volume only. Previous studies have reported positive 
associations between body adiposity and fibroglandular volume, as estimated by MRI (15) or 
mammography (28, 29), but null (30) or even inverse associations (31) have also been observed.  
Bone mineral density, as a proxy for cumulative exposure to endogenous estrogens, has been found to 
be positively associated with mammographic density (32) but no relationship between DXA % body 
bone mass, a proxy for bone density, and breast-tissue composition was observed in our study. 
Although ages at thelarche and menarche were found to be associated with % water, after 
adjustment for height and weight growth, these markers of pubertal development no longer influenced 
breast-tissue composition.  Previous research has provided evidence in favour of a positive association 
between age at menarche and breast density (6, 22), in opposition to the well-established inverse 
association between age at menarche and breast cancer risk (2). However, our findings are consistent 
with an Australian study that showed that age at menarche did not influence % density, or breast 
cancer risk, after accounting for childhood and adolescent BMI (8). These results indicate that it is the 
changes to the growth velocity during pubertal development, not their timing, which affect breast-
tissue composition.   
Plausibility 
Our findings are consistent with increasing evidence that height and weight growth in early 
life, when the mammary glands differentiate and the terminal structure of mammary tissue is 
determined, are markers of susceptibility to breast cancer later in life (3, 4). However, the specific 
mechanisms through which growth trajectories may influence breast-tissue composition in young 
adulthood, and through the latter subsequent breast cancer risk, are not well understood. Findings 
from Boyd et al. (15) suggest that the positive height – MRI % water association in premenopausal 
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women may be mediated by growth hormone. Growth factors, e.g. insulin-like growth factor-1, are 
known to be positively associated with breast cancer risk (33). Early-life body fatness may decrease 
the number of menstrual ovulatory cycles and hence reduce circulating levels of sex hormones (34); 
however, there is conflicting evidence on whether endogenous sex hormones affect breast density in 
pre-menopausal women (15, 35, 36). Childhood body fatness is also associated with lower levels of 
insulin-like growth factor-1 (37), and subsequently, slower adolescent growth, which may have a 
protective effect on breast cancer risk (3, 4).   
Conclusions 
These findings provide the strongest evidence so far that growth trajectories in early life 
influence breast-tissue composition in young adulthood and, together with recent evidence that 
density phenotypes track from young adulthood (38), they raise the prospect that high-risk women can 
be identified in young adulthood, at an age when they may benefit the most from early prevention 
strategies (e.g. chemoprevention, tailored screening). Longitudinal studies from puberty to young 
adulthood will help to further elucidate the early-life origins of breast-tissue composition.     
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TABLES 
Table 1. Puberty Measures, DXA % Body Fat and Bone Mass Measurements, and MRI Breast Tissue 
Composition of the Participants; ALSPAC study, 1991-2014   
Variable N % Mean (SD) Median (IQR) 
Puberty variables   
 
 
  
Age at menarche, years 469  12.7 (1.0) 12.7 (1.3) 
Age at thelarche, years a 486  10.4 (1.4) 10.2 (2.1) 
Age at breast development completion, years a 451  13.1 (1.6) 12.7 (1.5) 
Breast development duration, years a 426  2.9 (1.4) 2.7 (1.7) 
DXA measures b     
Age at DXA measures, years     
9  449  9.8 (0.3) 9.8 (0.3) 
11 461  11.7 (0.2) 11.8 (0.3) 
13.5  443  13.8 (0.2) 13.9 (0.3) 
15.5  423  15.4 (0.2) 15.5 (0.3) 
DXA body fat mass (%) at ages, years     
9  447  26.0 (8.2) 25.3 (11.3) 
11 460  27.2 (8.2) 26.7 (11.4) 
13.5  443  28.2 (8.0) 27.9 (11.9) 
15.5  428  30.0 (7.8) 29.1 (11.5) 
DXA body bone mass (%) at ages, years     
9  447  3.5 (0.4) 3.6 (0.5) 
11 460  3.7 (0.4) 3.7 (0.6) 
13.5 443  4.0 (0.4) 4.0 (0.6) 
15.5 428  4.2 (0.4) 4.2 (0.5) 
Participants characteristics at MRI examination 
 
 
  
Age (months)  491  257.9 (11.0) 259.0 (14.0) 
Menstrual phase c     
Follicular 70 14  
 
Luteal 50 10  
 
Taking hormone contraception 339 70  
 
Irregular period 28 6  
 
MRI breast measures d     
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DXA: dual-energy X-ray absorptiometry; IQR: inter-quartile range; MRI: magnetic resonance imaging; N: number of 
participants with information on each variable; SD: standard deviation  
a Age at thelarche and age at breast development completion estimated as described in the Methods section. Breast 
development duration estimated as age at breast development completion minus age at thelarche.   
b DXA % body bone and fat masses estimated as described in the Methods section.   
c Estimated for women who were not taking hormone contraception at the time of the MRI by calculating the number of days 
since last menstrual period (date of MRI – start of last menstrual period).  Luteal phase (day 14-17 to 28-31), follicular phase 
(day 0 to 14-17) and ‘irregular period’ (32+ days) were defined using self-reported average length of menstrual cycle. 
d Sections of the breast missing in the MRI images for one participant. Hence, % water could be estimated from the available 
MRI images, but not absolute volumetric measures (i.e. breast, fat and water volumes). 
Left-right average breast volume (cm3)  490  647.2 (461.1) 507.8 (469.2) 
Left-right average breast fat volume (cm3) 490  406.3 (349.5) 292.2 (327.9) 
Left-right average breast water volume (cm3) 490  240.9 (131.2) 209.8 (172.4) 
Left-right average breast % water  491  41.8 (10.3) 41.7 (16.0) 
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Table 2. Mutually-Adjusted Associations of MRI Breast Volume and % Water with Observed Measures of Height, Weight and DXA % Body Fat and Bone Masses, 
and Markers of Pubertal Development; ALSPAC study, 1991-2014 
 MRI Breast Volume MRI % Water 
Model 1 (N=287) Model 2 (N=261) Model 3 (N=244) Model 1 (N=287) Model 2 (N=261) Model 3 (N=244) 
Variable 
a
 RC 
b,c
 95% CI
 b,c
 RC
 b,d
 95% CI
 b,d
 RC
 b,e
 95% CI
 b,e
 RC
 b,c
 95% CI
 b,c
 RC
 b,d
 95% CI
 b,d
 RC
 b,e
 95% CI
 b,e
 
Birth length 1.00  0.93, 1.08 1.05  0.97, 1.14 1.02  0.95, 1.10 1.01  0.98, 1.05 0.99  0.96, 1.02 1.00  0.97, 1.03 
Pre-pubertal height growth f 0.86  0.74, 1.00 g 0.88 0.75, 1.03 0.93  0.78, 1.11 1.12  1.04, 1.20* 0.95  0.90, 1.01 0.93  0.87, 1.00 
Pubertal height growth h 0.84  0.75, 0.94 g 0.90 0.81, 1.01 0.89  0.78, 1.01 1.07  1.02, 1.14* 1.07  1.03, 1.12 g 1.07  1.02, 1.13 g 
Birth weight 0.99  0.92, 1.06 0.98 0.91, 1.05 1.00  0.93, 1.07 1.03  1.00, 1.07 1.03  1.00, 1.06 1.03  1.00, 1.06 g 
Pre-pubertal weight growth i 1.22 1.13, 1.32 g 1.21  1.07, 1.37 g 1.15  1.02, 1.30 g 0.87  0.84, 0.90* 1.05  1.00, 1.10 1.05  1.00, 1.11 
Pubertal weight growth j 1.78  1.68, 1.89 g 1.67 1.56, 1.80 g 1.70  1.58, 1.82 g 0.84  0.82, 0.87* 0.86  0.84, 0.89 g 0.86 0.84, 0.89 g 
Age at menarche  1.04  0.97, 1.12  1.05  0.97, 1.14 1.00  0.97, 1.04  1.00  0.97, 1.03 
Age at thelarche k 1.01 0.87, 1.16  1.04  0.88, 1.22 1.06 0.99, 1.14  1.02  0.96, 1.09 
Age at breast completion k 0.88  0 .83, 0.93 g  0.88  0.83, 0.94 g 1.00  0.97, 1.02  1.01  0.98, 1.03 
DXA body fat mass (%) l       
9 years   1.11  1.00, 1.23 1.13  1.02, 1.25 g  0.86  0.83, 0.90 g 0.86  0.83, 0.90 g 
9 – 11 years  1.04  0.96, 1.13 1.03  0.96, 1.11  0.94  0.92, 0.97 g 0.95  0.92, 0.98 g 
11 – 13.5 years  1.07  0.99, 1.15 1.08  1.00, 1.16  0.96  0.93, 0.98 g 0.96  0.93, 0.99 g 
13.5 – 15.5 years   0.98  0.92, 1.04 0.98  0.93, 1.04  0.99  0.96, 1.01 0.99  0.97, 1.02 
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DXA body bone mass (%) l         
9 years   1.01  0.94, 1.09 1.02  0.95, 1.09  1.03  1.00, 1.06 g 1.03  1.00, 1.06 g 
9  – 11 years  0.96  0.90, 1.02 0.96  0.90, 1.03  1.01  0.99, 1.04 1.02  0.99, 1.04 
11 – 13.5 years  0.93  0.86, 1.00 0.96  0.88, 1.03  0.97  0.95, 1.00 0.98  0.95, 1.01 
13.5 – 15.5 years   0.91  0.86, 0.97 g 0.91  0.86, 0.97 g  1.01  0.98, 1.03 1.01  0.99, 1.04 
CI: confidence interval; DXA: dual-energy X-ray absorptiometry; MRI: magnetic resonance imaging; RC: relative change per one standard deviation increment in the exposure variable of 
interest  
a All growth variables, and growth differences across ages, were standardised (see Methods section).  
b MRI breast measures were log transformed. Exponentiated estimated regression parameters are presented; 95% CI were calculated by exponentiating the original 95% CIs. RC estimates 
adjusted for age and menstrual phase at MRI examination and all the other variables included in the model.  
c Model 1 includes all the height/weight growth trajectory variables and the pubertal development variables;  
d Model 2 includes all the height/weight growth trajectory variables and the DXA measures;  
e Model 3 includes  all the height/weight growth trajectory variables, the pubertal development variables, and the DXA measures. 
f Pre-pubertal height growth calculated as ‘height at age of thelarche’ – ‘height at age 7 (±1) years’. 
g P < 0.05   
h Pubertal height growth calculated as ‘height at age 21 years’ – ‘height at age of thelarche’. 
i Pre-pubertal weight growth calculated as ‘weight at age of thelarche’ – ‘weight at age 7 (±1) years’. 
j Pubertal weight growth calculated as ‘weight at age 21 years’ – ‘weight at age of thelarche’ 
k Age at thelarche and age at breast development completion estimated as described in the Methods section. 
l DXA % body bone and fat masses estimated as described in the Methods section. These models include the relevant DXA measurements taken at age 9 years and their changes between ages 9 
to 11 years, 11 to 13.5 years, and 13.5 to 15.5 years.   
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FIGURES 
Figure 1. Average (and Interquartile Range) Height, Weight and DXA % Body Fat and Bone Mass 
Trajectories of the Participants from Age 7 to 21 Years, and Timing of Pubertal Development; 
ALSPAC study, 1991-2014 
Solid horizontal lines represent the (smoothed) median A) height, B) weight, and C) dual-energy X-ray absorptiometry 
(DXA) % body fat (upper line) and bone (lower line) masses; dashed horizontal lines represent the (smoothed) 25th and 75th 
centiles of their distributions. The dotted vertical line represents the median age at menarche. The vertical grey-shaded area 
indicates the time interval between the median age at thelarche (i.e. onset of breast development) and the median age at 
breast development completion (estimated as described in the Methods section). 
 
Figure 2. Associations of MRI Breast Measures with Observed Measures of Height and Weight, 
Pubertal Development and DXA % Body Fat and Bone Masses; ALSPAC study, 1991-2014 
Magnetic resonance imaging (MRI) A) breast volume and B) % water measures. Relative change (RC) estimates per one 
standard deviation increment in the exposure variable of interest (with 95% confidence interval (CI)) are adjusted for age 
and menstrual phase at MRI examination and all the other variables in the same category, i.e. height/weight growth 
trajectories, pubertal development or dual-energy X-ray absorptiometry (DXA) measures. Pre-pubertal and pubertal 
height/weight growth estimated as defined in the Methods section and in the footnotes f) to j) of Table 2.  
 
Figure 3. Mutually-Adjusted Associations of MRI Breast Measures with Height and Weight Velocity 
Trajectories; ALSPAC study, 1991-2014 
Magnetic resonance imaging (MRI) A) breast volume and B) % water measures. Relative change (RC) estimates per one 
standard deviation increment in the exposure variable of interest (with 95% confidence interval (CI)) were adjusted for age 
and menstrual phase at MRI examination and all the other variables listed in the graph. Height and weight growth measures 
from birth to age 10 years were derived using linear spline multilevel modelling of height and weight (16). From age 10 
years, standardised growth measures were calculated from a piecewise mixed effect model with knots at age 10, 12 and 15 
years (see Methods section, Web Tables 1-2 and Web Figures 1-2).  
   
 
 
 
 OR
IG
IN
AL
 U
NE
DI
TE
D 
MA
NU
SC
RI
PT
 
Downloaded from https://academic.oup.com/aje/advance-article-abstract/doi/10.1093/aje/kwx358/4622593
by London School of Hygiene & Tropical Medicine user
on 08 February 2018
A) B) C)
OR
IG
IN
AL
 U
NE
DI
TE
D 
MA
NU
SC
RI
PT
 
Downloaded from https://academic.oup.com/aje/advance-article-abstract/doi/10.1093/aje/kwx358/4622593
by London School of Hygiene & Tropical Medicine user
on 08 February 2018
0.8 1.0 1.2 1.4 1.6 1.8 
A) 
Relative Change  
Variable 
Birth length, cm 
Prepubertal height growth, cm 
Pubertal height growth, cm 
Birth weight, kg 
Prepubertal weight growth 
Pubertal weight growth, kg 
RC (95% CI) P-value 
1.04 (0.97, 1.12) 0.263 
0.81 (0.73, 0.91) <0.001 
0.84 (0.75, 0.92) 0.001 
0.96 (0.89, 1.03) 0.255 
1.23 (1.14, 1.34) <0.001 
1.79 (1.68, 1.89) <0.001 
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0.8 1.0 1.2 1.4 1.6 
RC (95% CI) P-value 
1.01 (0.97, 1.04) 0.752 
1.18 (1.12, 1.24) <0.001 
1.07 (1.03, 1.12) 0.002 
1.04 (1.01, 1.07) 0.017 
0.86 (0.83, 0.89) <0.001 
0.84 (0.82, 0.86) <0.001 
Relative Change  
B) 
Variable 
Birth length, cm 
Prepubertal height growth, cm 
Pubertal height growth, cm 
Birth weight, kg 
Prepubertal weight growth 
Pubertal weight growth, kg 
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0.8 0.9 1.0 1.1 
Relative Change 
Variable 
Age at onset of breast 
development, years 
Age at menarche, years 
Age at completion of breast 
development, years 
RC (95% CI) P-value 
0.90 (0.84, 0.98) 0.011 
1.01 (0.94, 1.09) 0.771 
0.86 (0.80, 0.93) <0.001 
C) 
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RC (95% CI) P-value 
1.06 (1.03, 1.10) <0.001 
1.04 (1.01, 1.07) 0.019 
0.99 (0.96, 1.02) 0.512 
Variable 
Age at onset of breast 
development, years 
Age at menarche, years 
Age at completion of breast 
development, years 
0.9 1.0 1.1 1.2 
Relative Change 
D) 
OR
IG
IN
AL
 U
NE
DI
TE
D 
MA
NU
SC
RI
PT
 
Downloaded from https://academic.oup.com/aje/advance-article-abstract/doi/10.1093/aje/kwx358/4622593
by London School of Hygiene & Tropical Medicine user
on 08 February 2018
RC (95% CI) P-value 
1.50 (1.37, 1.65) <0.001 
1.22 (1.13, 1.32) <0.001 
1.32 (1.23, 1.42) <0.001 
1.11 (1.04, 1.19) 0.002 
0.98 (0.91, 1.07) 0.689 
0.92 (0.86, 1.00) 0.036 
0.90 (0.83, 0.98) 0.014 
0.94 (0.88, 1.01) 0.088 
Variable and Age Group, years 
   DXA body fat,  %  
9 
9─11 
11─13.5 
13─15.5 
   DXA body bone, % 
9 
9─11 
11─13.5 
13-15.5 
0.9 1.1 1.3 1.5 
Relative Change 
E) 
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0.7 0.9 1.1 1.3 
RC (95% CI) P-value 
0.83 (0.80, 0.85) <0.001 
0.92 (0.90, 0.95) <0.001 
0.90 (0.88, 0.92) <0.001 
0.96 (0.94, 0.99) 0.001 
1.03 (1.00, 1.06) 0.051 
1.02 (0.99, 1.06) 0.027 
1.02 (0.99, 2.05) 0.267 
1.01 (0.99, 1.03) 0.417 
Relative Change 
F) 
Variable and Age Group, years 
   DXA body fat,  %  
9 
9─11 
11─13.5 
13─15.5 
   DXA body bone, % 
9 
9─11 
11─13.5 
13-15.5 OR
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Variable and Age Group 
   Height, cm 
Birth length 
0─3 months 
3─12 months 
1─3 years 
3─7 years 
7─10 years 
10─12 years 
12─15 years 
   Weight, kg 
Birth weight 
0─3 months 
3─12 months 
1─3 years 
3─7 years 
7─10 years 
10─12 years 
12─15 years 
15─21 years 
0.5 1.0 1.5 
A) 
Relative Change 
RC (95% CI) P-value 
0.98 (0.87,1.11) 0.812 
1.04 (0.85,1.27) 0.730 
0.88 (0.70,1.12) 0.310 
1.06 (0.85,1.13) 0.611 
0.91 (0.74,1.14) 0.406 
1.01 (0.91,1.03) 0.801 
0.98 (0.93,1.03) 0.449 
0.84 (0.78,0.89) <0.001 
0.95 (0.89,1.02) 0.160 
1.00 (0.95,1.05) 0.943 
1.00 (0.95,1.06) 0.997 
0.97 (0.91,1.03) 0.304 
0.97 (0.86,1.09) 0.566 
0.95 (0.85,1.05) 0.294 
1.28 (1.22,1.34) <0.001 
1.45 (1.39,1.52) <0.001 
1.46 (1.21,1.76) <0.001 
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B) 
0.8 0.9 1.0 1.1 1.2 
Relative Change 
RC (95% CI) P-value 
0.98 (0.93,1.03) 0.409 
1.06 (0.98,1.15) 0.150 
0.95 (0.86,1.04) 0.264 
1.10 (1.00,1.20) 0.051 
0.95 (0.87,1.03) 0.216 
1.06 (1.01,1.11) 0.018 
1.01 (0.99,1.03) 0.487 
1.05 (1.02,1.08) 0.001 
1.07 (1.04,1.10) <0.001 
1.01 (0.99,1.03) 0.191 
1.00 (0.98,1.03) 0.645 
1.02 (1.00,1.05) 0.106 
1.03 (0.98,1.09) 0.178 
1.03 (0.99,1.08) 0.142 
0.94 (0.92,0.96) <0.001 
0.89 (0.88,0.91) <0.001 
0.79 (0.73,0.85) <0.001 
Variable and Age Group 
   Height, cm 
Birth length 
0─3 months 
3─12 months 
1─3 years 
3─7 years 
7─10 years 
10─12 years 
12─15 years 
   Weight, kg 
Birth weight 
0─3 months 
3─12 months 
1─3 years 
3─7 years 
7─10 years 
10─12 years 
12─15 years 
15─21 years 
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